window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

drug development tools

  • Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain

    Thermo Fisher expands Orbitrap mass spectrometry portfolio with new AI-enabled platforms at ASMS 2026

    Thermo Fisher Scientific Inc. has announced a major expansion of [...]

    June 6, 2026
  • Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain

    Thermo Fisher launches Glacios 3 cryo-TEM to expand access to structural biology imaging

    Thermo Fisher Scientific has launched the Thermo Scientific Glacios 3 [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Medical devices

    Profusa launches Lumee tissue oxygen research offering to generate first commercial revenue

    Profusa has launched a research-use-only version of its Lumee tissue [...]

    May 5, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development

    Bio-Rad expands antibody and SpyCatcher ranges to support drug development and bioanalysis

    Bio-Rad Laboratories has introduced five new recombinant monoclonal anti-idiotypic antibodies [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Ten-year NHS study supports focal therapy for prostate cancer with fewer side effects
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Mission Therapeutics signs US$292M deal for acute kidney injury programme
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Research & Development
  • Medicus receives FDA feedback and IRB approval for Teverelix Phase 2 urinary retention trial
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top